Avenzo Therapeutics

Avenzo

The company develops oncology therapies, including small molecule inhibitors and antibody-drug conjugates, for patients with advanced solid tumours and metastatic breast cancer.

Avenge Bio

This biotechnology firm develops cell-based immunotherapies for patients with solid tumours, specifically targeting metastatic peritoneal cancers like ovarian cancer.

Tango Therapeutics

This biotechnology company develops precision oncology medicines targeting genetic vulnerabilities in cancer cells for patients with solid tumours.

Flamingo Therapeutics

This biotechnology company develops RNA-targeted therapies to treat various forms of cancer for patients with solid tumours.

Xilio Therapeutics

This biotechnology company develops tumour-activated immuno-oncology therapies designed to treat patients with solid cancers while reducing systemic side effects.

Arch Oncology

This biotechnology firm develops antibody therapies to treat patients with solid tumours and hematologic malignancies.

Tizona Therapeutics

This biopharmaceutical company develops first-in-class cancer immunotherapies and antibody-based treatments for patients with advanced solid tumours.

Akiram Therapeutics

This biotech company develops targeted radiopharmaceuticals and radioimmunotherapies for patients with solid tumours and metastatic cancers.